Posted inMarket Vaxcyte Strengthens Leadership Team and Accelerates Clinical Trial Timeline Vaxcyte appoints two new executive leaders and narrows the anticipated trial timeline for its key pneumococcal conjugate vaccine candidate. Posted by Prasenjit Bhowmik September 18, 2026
